The largest database of trusted experimental protocols

11 protocols using acquity ultra high performance liquid chromatography uplc system

1

Quantification of Vitamin D Metabolites by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were analyzed using an Acquity UPLC ultra-high-performance liquid chromatography system coupled with Xevo TQ-S triple quadrupole mass spectrometer (Waters Crop, Manchester, UK). Ionization was performed in electrospray ionization (ESI) mode and the mass spectrometer was operated in the positive ion electrospray mode. The temperature of the electrospray source was maintained at 120 °C and a desolvation temperature of 500 °C. The capillary voltage was set 3.5 V. Multiple reaction monitoring (MRM) mode was used to monitor and quantify VD metabolites. The mass spectrometry conditions used for detecting the analytes are shown in Table 1.

MRM transitions, collision energies and cone voltages of vitamin D metabolites.

CompoundMRM transitionsCone voltage(V)Collision energy(eV)
25(OH)D3407.31 > 389.244432
25(OH)D3-d3410.50 > 392.267722
1α,25(OH)2D3423.26 > 369.254922
1α,25(OH)2D3-d6429.36 > 374.366025
Chromatographic separation was performed using a Waters Acquity UPLC BEH C18 (100 × 2.1 mm, 1.7 µm), which was maintained at 40 °C in the column oven. The mobile phase was composed of lithium acetate (0.378 mM) aqueous solution (solvent A) and methanol (solvent B), with a total flow rate of 0.25 mL/min. The integration of the peak area and concentration calculation were done by the workstation UNIFI software (UNIFY 1.7.1.022).
+ Open protocol
+ Expand
2

Metabolomic Analysis by UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Instrumentation and reagents employed in this study include the Triple TOF 5600+ mass spectrometer (SCIEX, Framingham, MA, USA), the ACQUITY UPLC ultra-high-performance liquid chromatography system (Waters, Milford, MA, USA), the Allegra X-30R high-speed centrifuge (Beckman Coulter, Pasadena, CA, USA), a vortex mixer (IKA, Staufen, Germany), a Milli-Q A10 ultrapure water system (Millipore, Boston, MA, USA), a programmable ultrasonic processor (Kunshan Ultrasonic Instruments Company, Suzhou, China), and the following specific chemicals: methionine sulfoximine (MSO, Sigma-Aldrich, St. Louis, MI, USA), tricaine methanesulfonate (MS-222, Sigma-Aldrich, St. Louis, MI, USA), sodium bicarbonate, sodium chloride (analytical grade, Tianjin Tiantai Chemical Factory, Tianjin, China), methanol, acetonitrile, formic acid (mass spectrometry grade, Merck, Darmstadt, Germany), physiological saline (Sichuan Kelun Pharmaceutical Company, Chengdu, China), and organic-phase filter membranes (13 mm, 0.22 μm; Anpu, Shanghai, China).
+ Open protocol
+ Expand
3

Global Lipidomics of Murine Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissue (lobe 1) was obtained from 10-day-old mice and subjected to exhaustive solvent extraction for lipids. Global lipidomics analysis was performed on a Xevo G2-S quadrupole time-of-flight (Q-TOF) mass spectrometer (MS) interfaced with an Acquity ultra-high performance liquid chromatography (UPLC) system (Waters, Milford, MA) operated in electrospray ionization mode. An Acquity CSH C18 UPLC column was used to chromatographically separate components over 20 minute gradient elution. Compounds were ionized with electrospray and positive and negative ions acquired over the mass range 50-1200 Daltons with high resolution. Deconvolution, peak alignment, and preliminary normalization were conducted on raw metabolomics data with Progenesis QI (Waters). Each compound ion feature was annotated by elution time with m/z. Raw data were normalized by total compound ion intensity and with a global scalar derived from logarithm ratio of each sample to the reference. Accurate molecular mass (m/z) was used to search against HMDB and lipid MAPS database for putative identification.
+ Open protocol
+ Expand
4

Global Lipidomics of Murine Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissue (lobe 1) was obtained from 10-day-old mice and subjected to exhaustive solvent extraction for lipids. Global lipidomics analysis was performed on a Xevo G2-S quadrupole time-of-flight (Q-TOF) mass spectrometer (MS) interfaced with an Acquity ultra-high performance liquid chromatography (UPLC) system (Waters, Milford, MA) operated in electrospray ionization mode. An Acquity CSH C18 UPLC column was used to chromatographically separate components over 20 minute gradient elution. Compounds were ionized with electrospray and positive and negative ions acquired over the mass range 50-1200 Daltons with high resolution. Deconvolution, peak alignment, and preliminary normalization were conducted on raw metabolomics data with Progenesis QI (Waters). Each compound ion feature was annotated by elution time with m/z. Raw data were normalized by total compound ion intensity and with a global scalar derived from logarithm ratio of each sample to the reference. Accurate molecular mass (m/z) was used to search against HMDB and lipid MAPS database for putative identification.
+ Open protocol
+ Expand
5

UPLC-MS/MS Dapivirine Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatographic separation of dapivirine and 2H4-dapivirine was achieved using a Waters BEH C8, 50 × 2.1 mm UPLC column with a 1.7 μm particle size, on a Waters Acquity Ultra-High Performance Liquid Chromatography (UPLC) system (Waters Corporation, Milford, MA, USA). The mobile phase system used for separation consisted of water containing 0.1% formic acid (mobile phase A) and acetonitrile containing 0.1% formic acid (mobile phase B). The chromatographic method included a gradient elution from 30% to 50% mobile phase B over 2.0 min; dapivirine and its internal standard eluted at 1.35 min. The gradient was extended to 95% mobile phase B for 0.2 min, held at 95% mobile phase B for 0.4 min and the re-equilibrated to 30% mobile phase B over 0.1 min. The flow rate throughout the analytical run was 0.5 mL/min, and the analytical run time was 3.0 min.
Detection of dapivirine was performed using an API 5000 triple quadrupole mass analyzer (SCIEX, Redwood City, CA) using an ESI source operated in positive ionization and selective reaction monitoring (SRM) modes. Optimized declustering potential (170 V), collision energy (48 V) and exit potential (9 V) was determined for the analyte. Ion transitions monitored for dapivirine and 2H4-dapivirine were 330.2→158.1 m/z and 334.3→119.0 m/z, respectively.
+ Open protocol
+ Expand
6

Amino Acid Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amino acid analysis was performed at the SPARC Biocentre (Sick Kids, Toronto ON). Samples were vacuum dried, suspended in 6N HCl containing 1% phenol, and hydrolyzed for 24 h at 110 °C under nitrogen. Following hydrolysis, samples were vacuum dried to remove excess HCl, resuspended in a re-drying solution of methanol: water: trimethylamine (2:2:1) and dried under vacuum for 15 min. Samples were derivatized for 20 min at room temperature in methanol: water: trimethylamine: phenylisothiocyanate (7:1:1:1). The derivatizing solution was removed under vacuum, and the samples were washed with re-drying solution and vacuum dried for an additional 15 min. Samples were then dissolved in diluent and injected into an ethylene bridged hybrid C18 column to run on a modified Pico-Tag gradient at 48 °C, with phenylthiohydantoin (PTH)-derivatized amino acid detection occurring at 254 nm. A Waters Acquity Ultra-High Performance Liquid Chromatography (UPLC) System was used to control the chromatography. Cysteine quantification for select samples was performed by performic acid oxidation prior to hydrolysis.
+ Open protocol
+ Expand
7

Amino Acid Analysis by UPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were vacuum dried, suspended in 6N HCl containing 1% phenol, and hydrolyzed for 24 h at 110 °C under N2 stream. Following hydrolysis, samples were vacuum dried to remove excess HCl, resuspended in a methanol:water:trimethylamine (2:2:1) redrying solution and dried under vacuum for 15 min. Samples were derivatized for 20 min at room temperature in methanol:water:trimethylamine:phenylisothiocyanate (7:1:1:1) solution. This solution was then removed under vacuum, and the samples were washed with the redrying solution and vacuum dried for an additional 15 min. Chromatographic analysis was performed using a Waters Acquity Ultra-High Performance Liquid Chromatography (UPLC) System. Samples were dissolved and injected into an ethylene bridged hybrid C18 column, and a modified Pico-Tag gradient was used at 48 °C, with phenylthiohydantoin (PTH)-derivatized amino acid detection occurring at 254 nm. Cysteines were protected by performing acidic oxidation prior to hydrolysis. HPLC data correspond to the average of 4 replicates (Supplementary Table 11).
+ Open protocol
+ Expand
8

Brain Endothelial Cell Permeability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 10

The brain endothelial cell assay measures ability of compounds to cross a 2D brain microvascular layer. The assay is composed of two liquid-filled chambers separated by a semi-permeable membrane. Cells are propagated in endothelial cell growth media. The assay is performed in Hank's Balanced Salt Solution (HBSS).

The semi-permeable membrane is made of a polycarbonate membrane with pores of size 0.4 μM at a density of 1×108 pores/cm2 on which human cerebral microvascular endothelial cells (HCMECs) are grown in a monolayer. Cells were obtained under Material Transfer Agreement from Cornell University. A compound is added to the liquid in contact with the human cerebral microvascular endothelial cells on the membrane, and ability to pass through the cells is measured at 37° C. for time points ranging from zero to two hours. Compound is measured by quantifying the material in solution using the Waters Acquity ultra-high performance liquid chromatography (UPLC) system.

This assay was similarly applied to LLNL-02, which demonstrated improved capacity for crossing brain endothelial cells relative to existing reactivators (FIG. 16).

+ Open protocol
+ Expand
9

Characterization of Organic Compounds by NMR and MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
1H and 2D NMR experiments were recorded on a Varian Inova 750 MHz NMR spectrometer. 13C NMR spectra were recorded at 125 MHz in a Varian VNMRS-500-WB instrument (Agilent Technologies, Palo Alto, CA, USA). Chemical shifts (δ in ppm) are referenced to the carbon (δC 49.0) and residual proton (δH 3.31) signals of CD3OD. Mass spectra were obtained from a Xevo TQ mass spectrometer (Waters, Manchester, UK) connected to an ACQUITY Ultra High Performance Liquid Chromatography (UPLC) system (Waters, Manchester, UK). Purification was performed on a Waters HPLC system: Waters 2767 sample manager, Waters system fluidics organizer, Waters 2545 binary solvent manager, Waters 515 post-column HPLC pump, Waters 3100 mass detector. HRMS was acquired by Ion Trap-Time of Flight (IT-TOF) mass spectrometer instrument from Shimadzu (Kyoto, Japan)
+ Open protocol
+ Expand
10

UPLC-MS/MS Gradient Elution Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The UPLC-MS/MS system was equipped with an ACQUITY ultra-high performance liquid chromatography (UPLC) system (Waters Corporation, Milford, USA). The UPLC system was separated on a UPLC BEH C18 (50 mm × 2.1 mm, 1.7 μm) column (Temperature: 40 °C ). Acetonitrile (solution A) and 0.1% (v/v) formic acid in water (solution B) were selected as mobile phases for a created gradient elution. Gradient elution was performed at 5 µL injection volume and a flow rate of 0.35 mL/min for a total run time of 6 min. The specific gradient elution process is as follows: first, B runs at 95% for 0.8 min; second, linearly reduced from 95% B to 50% B for 0.8 to 3 min; third, linearly reducing from 50% B to 10% B for 4 to 5 min; and, finally, increasing linearity from 10% B to 95% B for 5.01 to 6 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!